Mallcom (India) FY26: Capacity Hoist, Margins Caught in Tariff Undertow
General information and entertainment, not investment advice. The author is not a SEBI-registered adviser or research analyst. No recommendation, no promised returns. Markets carry risk including loss of capital. Figures may not be current. Consult a registered adviser before acting.
1 — At a Glance
Mallcom grew topline 11% to ₹540 Cr in FY26, a creditable number shadowed by one sobering fact: net profit plunged 48% to ₹30 Cr.
The cause wasn’t operational chaos. It was a year bookended by export crises—U.S. tariffs for nearly the full year, EU demand that flatlined—forcing the company to cut prices to OEM buyers to defend order book. Meanwhile, raw materials kept rising.
Two shiny new factories (Sanand in Gujarat, Chandipur in West Bengal) are now live and in ramp mode. Sanand runs at roughly 50% utilization; the CFO flagged ₹40 Cr as the “minimum” annual revenue once it’s humming.
The company sits on net cash of ₹3 Cr and carries debt of ₹120 Cr against net worth of ₹318 Cr. Leverage is mild; interest cover is healthy at 5.95x. Domestic market grew 20% YoY, offsetting export slump.
The central tension: a company mid-investment cycle that has just crushed profits while building capacity for a recovery that depends on export demand healing.
2 — Introduction
Mallcom has been stitching together head-to-toe PPE kits since 1983.
The business is 90%+ repeat customers, which is what professional operators in factories and mines want: a vendor who shows up, delivers on spec, doesn’t vanish mid-season. That stickiness is rare in commoditized manufacturing and worth noting.
FY26 was stress-tested in ways the company hadn’t advertised for. U.S. customers faced tariff walls so steep that they either stopped buying Indian PPE or forced price concessions so deep that Mallcom’s order margins evaporated. Europe, historically 33% of exports, saw demand descriptions summed up by management as “bleak.” The company offered price cuts to keep the shelf space.
Domestically, a different story unfolded. Labor formalization codes and stricter BIS compliance standards meant more factories needed certified PPE. Mallcom, organized and scaled, gained ground. Management flagged 20% domestic growth in FY26—a genuine bright spot.
Two new plants came online: a workwear and hand-protection factory in Gujarat (PROTECH, ₹100 Cr capex), and an industrial safety shoes unit in West Bengal (₹25 Cr capex). Both are now commercially operational. Both are in utilization ramp.
The capital cycle is ending. FY27 guidance is ₹10–15 Cr capex, down from ₹34 Cr this year. Deleveraging is the next focus.
3 — Business Model: WTF Do They Even Do?
Mallcom does one thing with unyielding focus: industrial PPE in multiple shapes.
The portfolio spans helmets, eyewear, hearing protection, face masks, gloves (leather, nitrile, PU-coated—now in-house), safety garments (workwear and uniforms), and shoes (the highest-margin and fastest-growing segment). In FY26, shoes accounted for nearly 50% of revenue; garments and gloves split the rest almost evenly. High-margin products (shoes, garments) drove over 60% of revenue.
The company manufactures across 13 facilities: DTA (domestic), SEZ (export), and EOU units scattered across West Bengal, Uttarakhand, and Gujarat. It tests in-house.
Revenue split: 58% export, 42% domestic. Within exports, 33% lands in Europe, 17% in the Americas, 48% across Asia-MENA. Orders flow through two channels: white-label (OEM vendors supply major importers overseas; Mallcom makes the product, the buyer’s brand goes on), and branded (direct distributors in 55+ countries, 80+ distributor partners, 1000+ importers). Domestic is almost entirely branded and direct.
The margin architecture: gloves are low-margin grind. Shoes and garments are structural cash. Leather is premium; nitrile and synthetics are the volume plays. Export OEM work used to be margin-stable until tariffs and demand destroyed pricing.
Management just launched in-house PU gloves and PVC gumboots—import substitutes aimed at both domestic certification and export demand. The pitch: standardized quality, priced to compete with Chinese imports, margin profile “on similar lines” to company average. Not a margin explosion, just a basket-widening move.
New facility in UAE handles Middle East and Africa market development. The company sent eight traveling export salespeople to fairs and customer plants; no permanent overseas offices beyond UAE.
This is a B2B play selling to organized labor pools. It depends on two things: regulatory tightening (more PPE mandates, better enforcement) and rising worker awareness in emerging markets. Both are durable tailwinds. But near-term profits pivot on export realization—and that is currently a hostage.
4 — Financials Overview
Figures are consolidated, in ₹ crore.
Metric
FY26
FY25
FY24
YoY Change
Revenue
539.61
486.78
420.72
+10.85%
EBITDA
61.14
89.78
61.82
-31.99%
EBITDA Margin
11.34%
18.46%
14.69%
-1130 bps
PAT
30.04
57.43
36.32
-47.69%
EPS (annualized)
48.45
92.63
58.58
-47.73%
Key observations on the financials:
Revenue grew. EBITDA collapsed. PAT fell by nearly half. The story: raw material costs spiked (the company blames petro-based inputs and FX headwinds on imports), export realization declined steeply due to weak demand and pricing concessions, and employee costs rose as the company staffed up the new facilities in Gujarat and West Bengal. A one-time capital gain of ₹25 Cr from a land sale in FY25 also inflates that year’s PAT; strip it out, and FY25 earnings were ₹32.43 Cr, still well above FY26.
Operating margin fell 1,130 basis points YoY to 11.34%, the lowest in the 10-year history captured in this data set.
From the June 2026 concall:
Management acknowledged export OEM pressure explicitly: “demand situation has been very bleak,” particularly in Europe. The company revised domestic price lists twice in Q4 to pass through inflation, but export OEM contracts have long lead times and weak negotiating leverage for the vendor. “Even to maintain market share, we have to offer some concessions,” the CFO said.
Sanand, the new Gujarat workwear facility, is at ~50% utilization. The CFO indicated it could generate ₹40 Cr minimum annual revenue at current capacity. Chandipur in West Bengal is operational but also ramping.
Interest expense climbed to ₹8.2 Cr from ₹6.05 Cr, reflecting the debt raised for capex.
5 — Market Expectations & Historical Multiples
This section describes how the market is currently pricing the company and how that compares with its own history and peer group. It is descriptive, not predictive.
Metric
Current
5-Year Average
Peer Median
P/E
20.13x
17.70x
24.97x
EV/EBITDA
11.81x
—
—
P/B
1.91x
—
3.28x
ROE
9.74%
13.00%
13.17%
ROCE
11.40%
—
16.17%
The market currently prices Mallcom at 20.13x annualized earnings, above its own five-year median of 17.7x but below the peer median of 24.97x (which includes much larger and faster-growing industrial equipment makers).
The P/B ratio of 1.91x sits well below the peer set’s 3.28x, suggesting the market discounts Mallcom’s returns on equity (currently 9.74%, well below the peer median of 13.17%).
ROCE stands at 11.4%, also trailing the peer median of 16.17%. The company appears to be priced for a return-on-capital recovery, not for current profitability. ROCE compression in FY26 mirrors